Who makes Tocilizumab Injection [Actemra]?

Tocilizumab Injection [Actemra] is developed by Grupo de Investigación Clínica en Oncología Radioterapia.

What development phase is Tocilizumab Injection [Actemra] in?

Tocilizumab Injection [Actemra] is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Grupo de Investigación Clínica en Oncología Radioterapia · Phase 1 active Small molecule

Generic name	Tocilizumab Injection [Actemra]
Also known as	Actemra
Sponsor	Grupo de Investigación Clínica en Oncología Radioterapia
Modality	Small molecule
Phase	Phase 1

No approved indications tracked.

No common side effects on file.